Navigation Links
Angioplasty Should be the Standard

A new study finds angioplasty should be the treatment of choice for heart attack patients, even if the hospital they initially //go to doesn't offer angioplasty services and they have to be transferred to another facility for treatment.

Research has shown heart attack patients fare better when they are treated with angioplasty to open up the clogged blood vessel that caused the attack than when they are treated with a clot-busting drug therapy called fibrinolysis.

Danish investigators provide evidence reversing conventional wisdom. Their study involved around 1,500 heart attack patients at 24 hospitals without angioplasty services and five hospitals with such services. Patients at the 24 hospitals were randomly assigned to either treatment with fibrinolysis at the facility where they were first admitted or treatment with angioplasty at another hospital that offered the service, if they could be transferred to the new hospital within two hours.

Researchers analyzed results, looking at a combination of death, clinical evidence of another heart attack (reinfarction), or a disabling stroke within 30 days. Results showed patients who received angioplasty were significantly more likely to survive, regardless of whether they had been transferred to another hospital to receive the angioplasty or not. Overall, only 8.5 percent of the angioplasty group suffered a complication, compared to 14.2 percent of those in the fibrinolysis group. The primary benefit was a reduction in the rate of reinfarction among the angioplasty patients. Little difference was noted between the groups in death or stroke rates.
'"/>




Page: 1

Related medicine news :

1. Cholesterol Drug Helps After Angioplasty
2. The Success Rate Of Angioplasty In Female Patients Low
3. Angioplasty The Much Preferred Treatment Of Choice For Heart Attacks
4. Angioplasty death risk reduced by doubling drug dose
5. Angioplasty death risk reduced by doubling drug dose
6. A ray of hope in Angioplasty dilemma
7. Angioplasty plus stenting better than thrombolysis for elderly patients with AMI
8. Patients Fare Better With Doctors Who Do More Angioplasty Procedures
9. Researchers Begin Study To Find Out If Angioplasty Can Be Safely Done In Smaller Hospitals
10. Drug-Coated Stents Work Better In Diabetic Patients After Angioplasty
11. Togadiyas Condition Stable After Undergoing Angioplasty
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/26/2017)... (PRWEB) , ... September 26, 2017 , ... The 2017 ... Chicago, called “The Magic of Fat,” revealed not only the latest about cosmetic procedures ... to be an evolution in cosmetic medicine. , “Fat really is magical, especially when ...
(Date:9/26/2017)... ... September 26, 2017 , ... ... collaborating on strategic and tactical plans for Pittcon 2018. As of July 1, ... president along with his named vice president, Charles Gardner, (ChemImage Corporation) and selected ...
(Date:9/26/2017)... (PRWEB) , ... September 26, 2017 , ... “Good Morning ... faith, healing, and overcoming obstacles. “Good Morning Sunshine!: Finding Strength and Comfort in God” ... degree in psychology from Fort Hays Sate University, who has worked at a local ...
(Date:9/26/2017)... ... September 26, 2017 , ... “Sound of My Song”: an intriguing and thought-provoking ... author, Karmen Worden, a retired teacher with a passion for music and ancestral history. ... and inspiring story on loss, living with depression, and finding love through the journey. ...
(Date:9/26/2017)... ... 26, 2017 , ... “Sonflower Submission”: a relatable and concise reality of ... of negativity, complaining and the need to always be correct. There comes a time, ... a lesson in stress-less living to be learned. “Sonflower Submission” is the creation ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... Sept. 12, 2017  ValGenesis Inc., the global ... is pleased to announce the appointment of Dr. ... its Board of Directors and Chairman of Advisory ... life science companies to manage their entire validation ... paper in this process. Furthermore, ValGenesis VLMS enables ...
(Date:9/9/2017)... , Sept. 9, 2017  Eli Lilly and Company ... and secondary endpoint data for lasmiditan, an investigational, oral, ... demonstrated statistically significant improvements compared to placebo in the ... today at the 18th Congress of the International Headache ... "The data presented today demonstrate lasmiditan,s potential to ...
(Date:9/7/2017)... 2017 Caris Life Sciences, a leading ... promise of precision medicine, today announced results from ... its molecular profiling approach in guiding therapeutic strategies ... plus (CGP+) with Caris Molecular Intelligence ® ... molecular level, leading to more therapeutic options and ...
Breaking Medicine Technology: